dihydrocarminomycin has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Planque, MM; Lankelma, J; McVie, JG; Pinedo, HM; Ten Bokkel Huinink, WW; Weenen, H | 1 |
| de Planque, MM; Lankelma, J; Leyva, A; McVie, JG; Penders, PG; Pinedo, HM; Ten Bokkel-Huinink, WW | 1 |
2 other study(ies) available for dihydrocarminomycin and Breast Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of carminomycin in man: biweekly schedule vs single dose every three weeks.
Topics: Adult; Aged; Breast Neoplasms; Carubicin; Daunorubicin; Drug Administration Schedule; Female; Humans; Kinetics; Middle Aged | 1984 |
Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography.
Topics: Breast Neoplasms; Carubicin; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Sarcoma; Soft Tissue Neoplasms; Time Factors | 1982 |